W. Brooks Gentry

High Impact

Researcher

University of Arkansas for Medical Sciences

faculty

29 h-index 65 pubs 2,655 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

W. Brooks Gentry investigates the development of monoclonal antibodies for the treatment of methamphetamine use disorder. His research focuses on identifying lead candidate antibodies that demonstrate efficacy and safety in preclinical studies. Recent publications detail the comparison of chimeric and humanized antibodies, examining their pharmacological effects on methamphetamine's actions. Gentry's work also involves assessing cross-reactivity and locomotor activity to identify promising candidates for Investigational New Drug (IND)-enabling studies.

With a career marked by significant scholarly output, Gentry has authored 65 publications, accumulating 2,655 citations, and maintains an h-index of 29. He is recognized as a highly cited researcher. His collaborations include work with Michael D. Berquist and Melinda G. Gunnell at the University of Arkansas for Medical Sciences, with whom he shares multiple publications.

Metrics

  • h-index: 29
  • Publications: 65
  • Citations: 2,655

Selected Publications

  • Comparison between a chimeric anti-methamphetamine monoclonal antibody and humanized antibodies on pharmacological effects of methamphetamine (2025) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics